New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers design new hydrogel for more targeted cancer treatments

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro
Oncology December 22,2023
Researchers design new hydrogel for more targeted cancer treatments

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro
Oncology December 22,2023
New therapeutic strategy for chemotherapy resistance in ovarian cancer

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste
Oncology December 22,2023
New therapeutic strategy for chemotherapy resistance in ovarian cancer

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste
Oncology December 22,2023
Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor
Oncology December 22,2023
Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor
Oncology December 22,2023
Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber
Oncology December 22,2023
Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber
Oncology December 22,2023
'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the
Oncology December 22,2023
'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the
Oncology December 22,2023
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Oncology December 22,2023
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Oncology December 22,2023
New model explains how our immune system sometimes helps cancer spread

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in
Oncology December 22,2023
New model explains how our immune system sometimes helps cancer spread

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in
Oncology December 22,2023
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Oncology December 22,2023
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Oncology December 22,2023
Novel genetic signature that can predict some kinds of breast cancer is identified

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers
Oncology December 22,2023
Novel genetic signature that can predict some kinds of breast cancer is identified

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers
Oncology December 22,2023
Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can
Oncology December 22,2023
Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com